Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis

Liuyang Wang, Emily Ko, James J. Gilchrist, Kelly J. Pittman, Anna Rautanen, Matti Pirinen, J. Will Thompson, Laura G. Dubois, Raymond J. Langley, Sarah L. Jaslow,

Science Advances · 2017 · 58 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

had prolonged survival when MTA was administered before infection, suggesting that manipulating MTA levels could regulate the severity of the inflammatory response. Our results demonstrate how combining genetic data, biomolecule measurements, and animal models can shape our understanding of disease and lead to new biomarkers for patient stratification and potential therapeutic targeting.

References

39